Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Lung Cancer

Free Subscription Articles published in J Thorac Oncol Retrieve available abstracts of 95 articles: HTML format

Single Articles

May 2008
1. EINHORN LH , Bonomi P, Bunn PA Jr, Camidge DR, et al
   Summary report 7th Annual Targeted Therapies of the Treatment of Lung Cancer.
   J Thorac Oncol. 2008;3:545-55.
   PubMed     Related articles   
   
   
   
2. KASED N , Erasmus JJ, Komaki R, Cox JD, et al
   Prognostic value of posttreatment [18F] fluorodeoxyglucose uptake of primary non-small cell lung carcinoma treated with radiation therapy with or without chemotherapy: a brief review.
   J Thorac Oncol. 2008;3:534-8.
   PubMed     Related articles    Abstract available
   
   
   
3. LILENBAUM R , Raez L, Tseng J, Seigel L, et al
   Efficacy and safety of oxaliplatin and gemcitabine with bevacizumab in advanced non-small cell lung cancer.
   J Thorac Oncol. 2008;3:511-5.
   PubMed     Related articles    Abstract available
   
   
   
4. PALLIS AG , Polyzos A, Boukovinas I, Agelidou A, et al
   Pooled analysis of elderly patients with non-small cell lung cancer treated with front line docetaxel/gemcitabine regimen: the Hellenic Oncology Research Group experience.
   J Thorac Oncol. 2008;3:505-10.
   PubMed     Related articles    Abstract available
   
   
   
5. ERRIDGE SC , Murray B, Price A, Ironside J, et al
   Improved treatment and survival for lung cancer patients in South-East Scotland.
   J Thorac Oncol. 2008;3:491-8.
   PubMed     Related articles    Abstract available
   
   
   
6. SEKI N , Sawada S, Nakata M, Inoue T, et al
   Lung cancer with localized ground-glass attenuation represents early-stage adenocarcinoma in nonsmokers.
   J Thorac Oncol. 2008;3:483-90.
   PubMed     Related articles    Abstract available
   
   
   
7. KUYAMA S , Hotta K, Tabata M, Segawa Y, et al
   Impact of HER2 gene and protein status on the treatment outcome of cisplatin-based chemoradiotherapy for locally advanced non-small cell lung cancer.
   J Thorac Oncol. 2008;3:477-82.
   PubMed     Related articles    Abstract available
   
   
   
8. MACBETH F
   Measuring the outcomes of lung cancer treatment.
   J Thorac Oncol. 2008;3:455-6.
   PubMed     Related articles   
   
   
   April 2008
9. LUDOVINI V , Gori S, Pistola L, Fazia MA, et al
   Long-lasting complete remission with tyrosine kinase inhibitor in bronchioloalveolar carcinoma with a so far unknown EGFR mutation.
   J Thorac Oncol. 2008;3:452-3.
   PubMed     Related articles   
   
   
   
10. DUDEK AZ , Chereddy S, Nguyen S, Wagner JE, et al
    Neoadjuvant chemotherapy with reduced-dose carboplatin and gemcitabine for non-small cell lung cancer in a patient with Fanconi anemia.
    J Thorac Oncol. 2008;3:447-50.
    PubMed     Related articles    Abstract available
    
    
    
11. GRIDELLI C , Ardizzoni A, Ciardiello F, Hanna N, et al
    Second-line treatment of advanced non-small cell lung cancer.
    J Thorac Oncol. 2008;3:430-40.
    PubMed     Related articles    Abstract available
    
    
    
12. SCHULTZ EM , Silvestri GA, Gould MK
    Variation in experts' beliefs about lung cancer growth, progression, and prognosis.
    J Thorac Oncol. 2008;3:422-6.
    PubMed     Related articles    Abstract available
    
    
    
13. GOTO Y , Sekine I, Yamada K, Nokihara H, et al
    Influence of previous chemotherapy on the efficacy of subsequent docetaxel therapy in advanced non-small cell lung cancer patients.
    J Thorac Oncol. 2008;3:412-6.
    PubMed     Related articles    Abstract available
    
    
    
14. CORTINOVIS D , Bidoli P, Cullura D, Lorusso V, et al
    Is irinotecan plus docetaxel useful as second-line therapy in advanced non-small cell lung cancer?
    J Thorac Oncol. 2008;3:405-11.
    PubMed     Related articles    Abstract available
    
    
    
15. WONG AS , Soong R, Seah SB, Lim SW, et al
    Evidence for disease control with erlotinib after gefitinib failure in typical gefitinib-sensitive Asian patients with non-small cell lung cancer.
    J Thorac Oncol. 2008;3:400-4.
    PubMed     Related articles    Abstract available
    
    
    
16. DUDEK AZ , Larson T, McCleod MJ, Schneider DJ, et al
    Phase 1/2 dose escalating study of twice-monthly pemetrexed and gemcitabine in patients with advanced cancer and non-small cell lung cancer.
    J Thorac Oncol. 2008;3:394-9.
    PubMed     Related articles    Abstract available
    
    
    
17. KIURA K , Nakagawa K, Shinkai T, Eguchi K, et al
    A randomized, double-blind, phase IIa dose-finding study of Vandetanib (ZD6474) in Japanese patients with non-small cell lung cancer.
    J Thorac Oncol. 2008;3:386-93.
    PubMed     Related articles    Abstract available
    
    
    
18. AGARWALA A , Fisher W, Bruetman D, McClean J, et al
    Gefitinib plus celecoxib in chemotherapy-naive patients with stage IIIB/IV non-small cell lung cancer: a phase II study from the Hoosier Oncology Group.
    J Thorac Oncol. 2008;3:374-9.
    PubMed     Related articles    Abstract available
    
    
    
19. LUDOVINI V , Pistola L, Gregorc V, Floriani I, et al
    Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.
    J Thorac Oncol. 2008;3:365-73.
    PubMed     Related articles    Abstract available
    
    
    
20. MAROM EM , Martinez CH, Truong MT, Lei X, et al
    Tumor cavitation during therapy with antiangiogenesis agents in patients with lung cancer.
    J Thorac Oncol. 2008;3:351-7.
    PubMed     Related articles    Abstract available
    
    
    
21. BEAU-FALLER M , Ruppert AM, Voegeli AC, Neuville A, et al
    MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naive cohort.
    J Thorac Oncol. 2008;3:331-9.
    PubMed     Related articles    Abstract available
    
    
    March 2008
22. SCULIER JP , Meert AP
    Third-generation chemotherapy agents in the treatment of advanced non-small cell lung cancer: a meta-analysis.
    J Thorac Oncol. 2008;3:320.
    PubMed     Related articles   
    
    
    
23. STINCHCOMBE TE , Fried DB, Baggstrom MQ, Hensing TA, et al
    Third-Generation Chemotherapy Agents in the Treatment of Advanced Non-small Cell Lung Cancer: A Meta-Analysis.
    J Thorac Oncol. 2008;3:320-322.
    PubMed     Related articles   
    
    
    
24. RAJ JV , Coulden R, Entwisle J
    IASLC Lung Cancer Staging Project--a radiologist perspective.
    J Thorac Oncol. 2008;3:318-9.
    PubMed     Related articles   
    
    
    
25. BARBIERI V , Tassone P, Tagliaferri P
    The IASLC Lung Cancer Staging Project: revision proposal of pleural effusion and controlateral nodule staging.
    J Thorac Oncol. 2008;3:317.
    PubMed     Related articles   
    
    
    
26. RAMI-PORTA R , Postmus PE, Goldstraw P
    Reply to the Letter to the Editor Entitled The IASLC Lung Cancer Staging Project: Revision Proposal of Pleural Effusion and Contralateral Nodule Staging, by V. Barbieri, P. Tassone, and P. Tagliaferri.
    J Thorac Oncol. 2008;3:317-318.
    PubMed     Related articles   
    
    
    
27. BRUECKL WM , Schoeberl A, Wirtz RM, Murray S, et al
    Increased vascular-endothelial growth factor (VEGF) tumor expression and response to epidermal growth factor receptor (EGF-R) inhibitor erlotinib in non-small cell lung cancer (NSCLC).
    J Thorac Oncol. 2008;3:314-6.
    PubMed     Related articles    Abstract available
    
    
    
28. FONG T , Morgensztern D, Govindan R
    EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer.
    J Thorac Oncol. 2008;3:303-10.
    PubMed     Related articles    Abstract available
    
    
    
29. DETTERBECK F
    What to do with "Surprise" N2?: intraoperative management of patients with non-small cell lung cancer.
    J Thorac Oncol. 2008;3:289-302.
    PubMed     Related articles    Abstract available
    
    
    
30. RAMALINGAM S , Forster J, Naret C, Evans T, et al
    Dual inhibition of the epidermal growth factor receptor with cetuximab, an IgG1 monoclonal antibody, and gefitinib, a tyrosine kinase inhibitor, in patients with refractory non-small cell lung cancer (NSCLC): a phase I study.
    J Thorac Oncol. 2008;3:258-64.
    PubMed     Related articles    Abstract available
    
    
    
31. STINCHCOMBE TE , Morris DE, Lee CB, Moore DT, et al
    Induction chemotherapy with carboplatin, irinotecan, and paclitaxel followed by high dose three-dimension conformal thoracic radiotherapy (74 Gy) with concurrent carboplatin, paclitaxel, and gefitinib in unresectable stage IIIA and stage IIIB non-small c
    J Thorac Oncol. 2008;3:250-7.
    PubMed     Related articles    Abstract available
    
    
    
32. TOURNOY KG , Ryck FD, Vanwalleghem L, Praet M, et al
    The yield of endoscopic ultrasound in lung cancer staging: does lymph node size matter?
    J Thorac Oncol. 2008;3:245-9.
    PubMed     Related articles    Abstract available
    
    
    
33. STEVENS W , Stevens G, Kolbe J, Cox B, et al
    Ethnic differences in the management of lung cancer in New Zealand.
    J Thorac Oncol. 2008;3:237-44.
    PubMed     Related articles    Abstract available
    
    
    
34. HIRSH V , Major PP, Lipton A, Cook RJ, et al
    Zoledronic acid and survival in patients with metastatic bone disease from lung cancer and elevated markers of osteoclast activity.
    J Thorac Oncol. 2008;3:228-36.
    PubMed     Related articles    Abstract available
    
    
    
35. OU SH , Zell JA
    Validation study of the proposed IASLC staging revisions of the T4 and M non-small cell lung cancer descriptors using data from 23,583 patients in the California Cancer Registry.
    J Thorac Oncol. 2008;3:216-27.
    PubMed     Related articles    Abstract available
    
    
    
36. QIAN J , Massion PP
    Role of chromosome 3q amplification in lung cancer.
    J Thorac Oncol. 2008;3:212-5.
    PubMed     Related articles    Abstract available
    
    
    February 2008
37. PARK GM , Han KS, Chang YH, Kim CH, et al
    Immune hemolytic anemia after treatment with pemetrexed for lung cancer.
    J Thorac Oncol. 2008;3:196-7.
    PubMed     Related articles   
    
    
    
38. JONES LW , Eves ND, Mackey JR, Peddle CJ, et al
    Systemic inflammation, cardiorespiratory fitness, and quality of life in patients with advanced non-small cell lung cancer.
    J Thorac Oncol. 2008;3:194-5.
    PubMed     Related articles   
    
    
    
39. VIDAVER RM , Schachter BS
    2007 Annual Meeting of the National Lung Cancer Partnership: a summary of meeting highlights.
    J Thorac Oncol. 2008;3:190-3.
    PubMed     Related articles    Abstract available
    
    
    
40. CHANG JY , Dong L, Liu H, Starkschall G, et al
    Image-guided radiation therapy for non-small cell lung cancer.
    J Thorac Oncol. 2008;3:177-86.
    PubMed     Related articles    Abstract available
    
    
    
41. DECOSTER L , Stroobants S, Verbeken E, Nackaerts K, et al
    An unexpected abdominal 18F-fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET) in a patient with limited stage small cell lung cancer.
    J Thorac Oncol. 2008;3:174-6.
    PubMed     Related articles    Abstract available
    
    
    
42. FROESCHL S , Nicholas G, Gallant V, Laurie SA, et al
    Outcomes of second-line chemotherapy in patients with relapsed extensive small cell lung cancer.
    J Thorac Oncol. 2008;3:163-9.
    PubMed     Related articles    Abstract available
    
    
    
43. GRAZIANO SL , Herndon JE 2nd, Socinski MA, Wang X, et al
    Phase II trial of weekly dose-dense paclitaxel in extensive-stage small cell lung cancer: cancer and leukemia group B study 39901.
    J Thorac Oncol. 2008;3:158-62.
    PubMed     Related articles    Abstract available
    
    
    
44. GOTTFRIED M , Ramlau R, Krzakowski M, Ziolo G, et al
    Cisplatin-based three drugs combination (NIP) as induction and adjuvant treatment in locally advanced non-small cell lung cancer: final results.
    J Thorac Oncol. 2008;3:152-7.
    PubMed     Related articles    Abstract available
    
    
    
45. STINCHCOMBE TE , Harper HD, Hensing TA, Moore DT, et al
    The feasibility of adjuvant carboplatin and docetaxel in patients with curatively resected non-small cell lung cancer.
    J Thorac Oncol. 2008;3:145-51.
    PubMed     Related articles    Abstract available
    
    
    
46. JENA A , Taneja S, Talwar V, Sharma JB, et al
    Magnetic resonance (MR) patterns of brain metastasis in lung cancer patients: correlation of imaging findings with symptom.
    J Thorac Oncol. 2008;3:140-4.
    PubMed     Related articles    Abstract available
    
    
    
47. MORGENSZTERN D , Goodgame B, Baggstrom MQ, Gao F, et al
    The effect of FDG-PET on the stage distribution of non-small cell lung cancer.
    J Thorac Oncol. 2008;3:135-9.
    PubMed     Related articles    Abstract available
    
    
    
48. GOODGAME B , Pillot GA, Yang Z, Shriki J, et al
    Prognostic value of preoperative positron emission tomography in resected stage I non-small cell lung cancer.
    J Thorac Oncol. 2008;3:130-4.
    PubMed     Related articles    Abstract available
    
    
    
49. LILENBAUM RC , Cashy J, Hensing TA, Young S, et al
    Prevalence of poor performance status in lung cancer patients: implications for research.
    J Thorac Oncol. 2008;3:125-9.
    PubMed     Related articles    Abstract available
    
    
    
50. RECKAMP KL , Gardner BK, Figlin RA, Elashoff D, et al
    Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin.
    J Thorac Oncol. 2008;3:117-24.
    PubMed     Related articles    Abstract available
    
    
    
51. CARDEN CP , O'Brien ME
    Small-cell lung cancer, getting smaller but still difficult to treat.
    J Thorac Oncol. 2008;3:103-4.
    PubMed     Related articles   
    
    
    
52. HOWE KL , Leighl NB
    Factors contributing to adjuvant therapy decisions.
    J Thorac Oncol. 2008;3:195-6.
    PubMed     Related articles   
    
    
    
53. SOS ML , Zander T, Thomas RK, Staratschek-Jox A, et al
    Expression of signaling mediators downstream of EGF-receptor predict sensitivity to small molecule inhibitors directed against the EGF-receptor pathway.
    J Thorac Oncol. 2008;3:170-3.
    PubMed     Related articles    Abstract available
    
    
    
54. MARKS JL , Broderick S, Zhou Q, Chitale D, et al
    Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma.
    J Thorac Oncol. 2008;3:111-6.
    PubMed     Related articles    Abstract available
    
    
    
55. KRYSAN K , Lee JM, Dohadwala M, Gardner BK, et al
    Inflammation, epithelial to mesenchymal transition, and epidermal growth factor receptor tyrosine kinase inhibitor resistance.
    J Thorac Oncol. 2008;3:107-10.
    PubMed     Related articles    Abstract available
    
    
    
56. MOK TS , Crowley J
    Big question, small answer.
    J Thorac Oncol. 2008;3:105-6.
    PubMed     Related articles   
    
    
    January 2008
57. AZZOLI CG , Park BJ, Pao W, Zakowski M, et al
    Molecularly tailored adjuvant chemotherapy for resected non-small cell lung cancer: a time for excitement and equipoise.
    J Thorac Oncol. 2008;3:84-93.
    PubMed     Related articles    Abstract available
    
    
    
58. DAVIES AM , Ruel C, Lara PN, Lau DH, et al
    The proteasome inhibitor bortezomib in combination with gemcitabine and carboplatin in advanced non-small cell lung cancer: a California Cancer Consortium Phase I study.
    J Thorac Oncol. 2008;3:68-74.
    PubMed     Related articles    Abstract available
    
    
    
59. CHOONG NW , Vokes EE, Haraf DJ, Tothy PK, et al
    Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer.
    J Thorac Oncol. 2008;3:59-67.
    PubMed     Related articles    Abstract available
    
    
    
60. ASAMURA H , Goya T, Koshiishi Y, Sohara Y, et al
    A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers.
    J Thorac Oncol. 2008;3:46-52.
    PubMed     Related articles    Abstract available
    
    
    
61. DETTERBECK FC , Socinski MA, Gralla RJ, Edelman MJ, et al
    Neoadjuvant chemotherapy with gemcitabine-containing regimens in patients with early-stage non-small cell lung cancer.
    J Thorac Oncol. 2008;3:37-45.
    PubMed     Related articles    Abstract available
    
    
    
62. DE MARINIS F , Pereira JR, Fossella F, Perry MC, et al
    Lung Cancer Symptom Scale outcomes in relation to standard efficacy measures: an analysis of the phase III study of pemetrexed versus docetaxel in advanced non-small cell lung cancer.
    J Thorac Oncol. 2008;3:30-6.
    PubMed     Related articles    Abstract available
    
    
    
63. DU W , Mood D, Gadgeel S, Simon MS, et al
    An educational video to increase clinical trials enrollment among lung cancer patients.
    J Thorac Oncol. 2008;3:23-9.
    PubMed     Related articles    Abstract available
    
    
    
64. BOZZETTI C , Tiseo M, Lagrasta C, Nizzoli R, et al
    Comparison between epidermal growth factor receptor (EGFR) gene expression in primary non-small cell lung cancer (NSCLC) and in fine-needle aspirates from distant metastatic sites.
    J Thorac Oncol. 2008;3:18-22.
    PubMed     Related articles    Abstract available
    
    
    
65. BERGHMANS T , Dusart M, Paesmans M, Hossein-Foucher C, et al
    Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European L
    J Thorac Oncol. 2008;3:6-12.
    PubMed     Related articles    Abstract available
    
    
    
66. PETRELLA F , Leo F, Veronesi G, Solli P, et al
    "Salvage" surgery for primary mediastinal malignancies: is it worthwhile?
    J Thorac Oncol. 2008;3:53-8.
    PubMed     Related articles    Abstract available
    
    
    
67. INAMURA K , Takeuchi K, Togashi Y, Nomura K, et al
    EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers.
    J Thorac Oncol. 2008;3:13-7.
    PubMed     Related articles    Abstract available
    
    
    December 2007
68. VAN MEERBEECK JP , Van Schil PE, Senan S
    Reply: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer.
    J Thorac Oncol. 2007;2:1138-9.
    PubMed     Related articles   
    
    
    
69. DIZDAR O , Harputluoglu H, Dede DS, Altundag K, et al
    Adjuvant use of epidermal growth factor receptor kinase inhibitors may prevent bone metastases in patients with non-small cell lung carcinoma.
    J Thorac Oncol. 2007;2:1136.
    PubMed     Related articles   
    
    
    
70. COSTA DB , Kobayashi S, Schumer ST
    Erlotinib-associated alopecia in a lung cancer patient.
    J Thorac Oncol. 2007;2:1136-8.
    PubMed     Related articles   
    
    
    
71. RIMNER A , Rosenzweig KE
    Palliative radiation for lung cancer metastases to the breast: two case reports.
    J Thorac Oncol. 2007;2:1133-5.
    PubMed     Related articles    Abstract available
    
    
    
72. ROENHORST AW , van den Bergh AC, van Putten JW, Smit EF, et al
    Iris metastasis in small-cell lung carcinoma.
    J Thorac Oncol. 2007;2:1128-9.
    PubMed     Related articles    Abstract available
    
    
    
73. DAVIES AM , Ho C, Metzger AS, Beckett LA, et al
    Phase I study of two different schedules of bortezomib and pemetrexed in advanced solid tumors with emphasis on non-small cell lung cancer.
    J Thorac Oncol. 2007;2:1112-6.
    PubMed     Related articles    Abstract available
    
    
    
74. HOANG JK , Patz E Jr, Giroux D, Goldstraw P, et al
    Frequency and prognostic significance of preoperatively detected enlarged regional lymph nodes in patients with pathological stage I non-small cell lung cancer following resection.
    J Thorac Oncol. 2007;2:1103-6.
    PubMed     Related articles    Abstract available
    
    
    
75. TANVETYANON T , Soares HP, Djulbegovic B, Jacobsen PB, et al
    A systematic review of quality of life associated with standard chemotherapy regimens for advanced non-small cell lung cancer.
    J Thorac Oncol. 2007;2:1091-7.
    PubMed     Related articles    Abstract available
    
    
    
76. ZELL JA , Ignatius Ou SH, Ziogas A, Anton-Culver H, et al
    Validation of the proposed International Association for the Study of Lung Cancer non-small cell lung cancer staging system revisions for advanced bronchioloalveolar carcinoma using data from the California Cancer Registry.
    J Thorac Oncol. 2007;2:1078-85.
    PubMed     Related articles    Abstract available
    
    
    
77. SHEPHERD FA , Crowley J, Van Houtte P, Postmus PE, et al
    The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer.
    J Thorac Oncol. 2007;2:1067-77.
    PubMed     Related articles    Abstract available
    
    
    
78. SAKAO Y , Miyamoto H, Oh S, Takahashi N, et al
    Clinicopathological factors associated with unexpected N3 in patients with mediastinal lymph node involvement.
    J Thorac Oncol. 2007;2:1107-11.
    PubMed     Related articles    Abstract available
    
    
    
79. MATSUOKA K , Sumitomo S, Misaki N
    Prognostic factors in patients with pathologic T1-2N1M0 disease in non-small cell carcinoma of the lung.
    J Thorac Oncol. 2007;2:1098-102.
    PubMed     Related articles    Abstract available
    
    
    
80. BOLDRINI L , Gisfredi S, Ursino S, Camacci T, et al
    Mutational analysis in cytological specimens of advanced lung adenocarcinoma: a sensitive method for molecular diagnosis.
    J Thorac Oncol. 2007;2:1086-90.
    PubMed     Related articles    Abstract available
    
    
    
81. ROSELL R , Mendez P, Isla D, Taron M, et al
    Platinum resistance related to a functional NER pathway.
    J Thorac Oncol. 2007;2:1063-6.
    PubMed     Related articles   
    
    
    November 2007
82. SATOH H , Ohara G, Hizawa N
    Primary synovial sarcoma of the chest wall.
    J Thorac Oncol. 2007;2:1060.
    PubMed     Related articles   
    
    
    
83. KOHMO S , Tachibana I, Osaki T, Goya S, et al
    Multiple organ mucosa-associated lymphoid tissue lymphoma presenting with lymphangitic pattern of spread in the lung.
    J Thorac Oncol. 2007;2:1057-9.
    PubMed     Related articles   
    
    
    
84. CASALI C , Rossi G, Siopis E, Fontana G, et al
    Paraffinoma and carcinoid tumorlet: a hitherto unreported association mimicking lung cancer.
    J Thorac Oncol. 2007;2:1052-3.
    PubMed     Related articles   
    
    
    
85. CHOROSTOWSKA-WYNIMKO J , Szpechcinski A
    The impact of genetic markers on the diagnosis of lung cancer: a current perspective.
    J Thorac Oncol. 2007;2:1044-51.
    PubMed     Related articles    Abstract available
    
    
    
86. FUJII M , Kiura K, Takigawa N, Takeda H, et al
    Super scan using positron emission tomography in lung cancer patients.
    J Thorac Oncol. 2007;2:1042-3.
    PubMed     Related articles   
    
    
    
87. PANDYA KJ , Dahlberg S, Hidalgo M, Cohen RB, et al
    A randomized, phase II trial of two dose levels of temsirolimus (CCI-779) in patients with extensive-stage small-cell lung cancer who have responding or stable disease after induction chemotherapy: a trial of the Eastern Cooperative Oncology Group (E1500
    J Thorac Oncol. 2007;2:1036-41.
    PubMed     Related articles    Abstract available
    
    
    
88. OXNARD GR , Fidias P, Muzikansky A, Sequist LV, et al
    Non-small cell lung cancer in octogenarians: treatment practices and preferences.
    J Thorac Oncol. 2007;2:1029-35.
    PubMed     Related articles    Abstract available
    
    
    
89. YENDAMURI S , Komaki RR, Correa AM, Allen P, et al
    Comparison of limited surgery and three-dimensional conformal radiation in high-risk patients with stage I non-small cell lung cancer.
    J Thorac Oncol. 2007;2:1022-8.
    PubMed     Related articles    Abstract available
    
    
    
90. ILIC N , Petricevic A, Arar D, Kotarac S, et al
    Skip mediastinal nodal metastases in the IIIa/N2 non-small cell lung cancer.
    J Thorac Oncol. 2007;2:1018-21.
    PubMed     Related articles    Abstract available
    
    
    
91. BROKX HA , Visser O, Postmus PE, Paul MA, et al
    Surgical treatment for octogenarians with lung cancer: results from a population-based series of 124 patients.
    J Thorac Oncol. 2007;2:1013-7.
    PubMed     Related articles    Abstract available
    
    
    
92. DE JONG WK , van der Heijden HF, Pruim J, Dalesio O, et al
    Prognostic value of different metabolic measurements with fluorine-18 fluorodeoxyglucose positron emission tomography in resectable non-small cell lung cancer: a two-center study.
    J Thorac Oncol. 2007;2:1007-12.
    PubMed     Related articles    Abstract available
    
    
    
93. LO DS , Zeldin RA, Skrastins R, Fraser IM, et al
    Time to treat: a system redesign focusing on decreasing the time from suspicion of lung cancer to diagnosis.
    J Thorac Oncol. 2007;2:1001-6.
    PubMed     Related articles    Abstract available
    
    
    
94. KEMP RA , Reinders DM, Turic B
    Detection of lung cancer by automated sputum cytometry.
    J Thorac Oncol. 2007;2:993-1000.
    PubMed     Related articles    Abstract available
    
    
    
95. NEMENOFF RA
    Peroxisome proliferator-activated receptor-gamma in lung cancer: defining specific versus "off-target" effectors.
    J Thorac Oncol. 2007;2:989-92.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: